Worldwide Clinical Trials

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research 130

Research Clinical Trials Clinical Trials Immune Response 130

Rethinking Clinical Trials

DECEMBER 3, 2024

In a new report from the NIH Pragmatic Trials Collaboratory, a team of bioethicists explores the ethical obligation to share aggregate results from pragmatic clinical trials with research participants. There is growing appreciation of the importance of sharing aggregate results of clinical trials with research participants.

Trials 120

Trials Clinical Trials Clinical Trials Research 120

AuroBlog - Aurous Healthcare Clinical Trials blog

MAY 16, 2023

In a move to strengthen the country’s health infrastructure and to integrate and mainstream Ayush sector, the Ministry of Ayush and the Indian Council of Medical Research (ICMR) have signed a Memorandum of Agreement (MoA).The The MoA is for collaboration and cooperation in health research in the field of integrated medicine.

Medicine 189

Medicine Research Clinical Trials Clinical Trials 189

Bio Pharma Dive

OCTOBER 21, 2024

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

Research 260

Research Medicine 260

Bio Pharma Dive

JANUARY 12, 2025

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.

Medicine 210

Medicine Research 210

Bio Pharma Dive

JANUARY 7, 2025

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.

Gene Editing 297

Gene Editing Gene Research Medicine 297

Bio Pharma Dive

OCTOBER 2, 2020

Under his leadership, Merck developed a once overlooked cancer drug into Keytruda, now a top-selling medicine and foundational treatment for more than a dozen types of tumors.

Research 324

Research Medicine Development Drugs 324

Bio Pharma Dive

JULY 14, 2021

Formed around research from the Broad Institute's David Liu and Andrew Anzalone, Prime has attracted significant funding from a wide range of high-profile biotech backers.

Gene Editing 310

Gene Editing Medicine Gene Research 310

Pharmaceutical Technology

FEBRUARY 11, 2025

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer medicines to LMICs.

Medicine 200

Medicine Research 200

Bio Pharma Dive

OCTOBER 11, 2022

Launched last year to change how drugs for brain diseases are made, the biotech has now raised about $650 million to build a pipeline that includes two clinical-stage medicines.

Research 327

Research Medicine Drugs 327

Pharmaceutical Technology

OCTOBER 2, 2023

The Physiology and Medicine Prize has gone to two researchers whose work laid the foundation for Pfizer and Moderna’s Covid-19 vaccines.

Vaccination 257

Vaccination Vaccine Research Medicine 257

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 10, 2024

By focusing on clinical excellence, comprehensive education, and cutting-edge research, the Arya Vaidya Pharmacy Research Foundation (AVPRF) based in Coimbatore is ensuring that ayurvedic practices are validated, credible, and relevant for future generations.

Medicine 233

Medicine Pharmacy Research Clinical Trials 233

Pharmaceutical Technology

MAY 4, 2023

Roche has opened a new institute to accelerate research and development (R&D) in the area of human model systems such as organoids. Researchers at IHB will study human biology and speed up the adoption of human model systems in pharmaceutical R&D in addition to clinical practice.

Research 321

Research Scientist Medicine Development 321

Pharmaceutical Technology

JULY 7, 2022

But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. A new frontier in cancer research. It is certainly a pivotal moment for the cell and gene industry, with the next decade of R&D and clinical trials expected to transform the future of medicine.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

Bio Pharma Dive

FEBRUARY 28, 2023

An alliance with the startup brings Vertex an RNA-based medicine for the disease, adding to a portfolio that already includes a gene editing treatment.

Gene Editing 271

Gene Editing RNA Gene Research 271

Bio Pharma Dive

OCTOBER 19, 2023

The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.

Research 281

Research Medicine 281

Bio Pharma Dive

SEPTEMBER 8, 2021

The company, which focuses on self-replicating RNA, comes equipped with $40 million from Apple Tree Partners and a stamp of approval from the former research head at Biogen.

RNA 272

RNA Medicine Research 272

Rethinking Clinical Trials

MARCH 19, 2025

Blood is an instructor of medicine and associate director of the Accelerator for Clinical Transformation Research Group at Harvard Medical School and a cardiologist and intensivist at Brigham and Women’s Hospital. ” The Grand Rounds session will be held on Friday, March 21, 2025, at 1:00 pm eastern. Join the online meeting.

Clinical Trials 196

Clinical Trials Clinical Trials Trials Medicine 196

Pharma Times

APRIL 12, 2024

Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions

Medicine 142

Medicine Research Development Production 142

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 17, 2024

Biology is opening up new frontiers in medicine. We are witnessing a revolution in healthcare, driven by advances in genetics, Omics, RNA and CRISPR gene-editing technology, to deliver precision and personalised medicine, said Kiran Mazumdar-Shaw, executive chairperson, Biocon and Biocon Biologics.

Genetic Disease 189

Genetic Disease Genetics Gene Editing Medicine 189

Pharmaceutical Technology

FEBRUARY 21, 2025

Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule medicines.

Medicine 147

Medicine Development Research 147

Medical Xpress

MARCH 7, 2025

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach to promoting cardiomyocyte proliferation. The researchers are from the Michael E.

Medicine 124

Medicine Research 124

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. The company stated that bringing together advanced formulation discovery and generative AI will help in designing new mRNA medicines with optimal safety and performance.

Research 246

Research Gene Therapy Gene Scientist 246

Bio Pharma Dive

DECEMBER 1, 2022

The regulatory OK, a milestone for microbiome-based drug research, is for a medicine from Ferring Pharma that treats a recurrent type of gut infection.

FDA Approval 358

FDA Approval Medicine Drugs Research 358

Bio Pharma Dive

NOVEMBER 9, 2021

The biotech is researching how to make medicines from transfer RNA molecules. Encouraged by Moderna's success, Flagship Pioneering has been busy creating startups like Alltrna, which launched Tuesday.

RNA 359

RNA Medicine Drugs Research 359

Bio Pharma Dive

JUNE 26, 2021

Results published in The New England Journal of Medicine offer the first clinical evidence that CRISPR gene editing inside the body can be safe and effective, a culmination of years of scientific research.

Gene Editing 363

Gene Editing Gene Medicine Research 363

Bio Pharma Dive

JULY 24, 2023

The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.

Pharma Companies 246

Pharma Companies Research Medicine Drugs 246

Bio Pharma Dive

AUGUST 16, 2023

The struggling biotech also plans to offload other cell therapy assets, including a multiple myeloma therapy, and focus exclusively on gene editing medicines.

Gene Editing 246

Gene Editing Gene Research Medicine 246

Bio Pharma Dive

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Research 232

Research Medicine Drugs 232

Bio Pharma Dive

NOVEMBER 21, 2024

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to overcome the looming loss of exclusivity for some of its top-selling medicines.

Scientist 314

Scientist Medicine Research 314

Bio Pharma Dive

AUGUST 17, 2021

Lilly Bio-Medicines will be split into separate neuroscience and immunology groups, while the Loxo cancer research division will merge with Lilly Oncology.

Medicine 327

Medicine Drugs Research 327

Pharmaceutical Technology

OCTOBER 15, 2024

digital twins can be used to progress healthcare, drug development, and research by enabling the delivery of personalised medicine.

Medicine 130

Medicine Development Drugs Research 130

Bio Pharma Dive

NOVEMBER 29, 2022

In this continuing series, BioPharma Dive examines new areas of biotech investment and startup activity, such as next-generation RNA medicines, TYK2 inhibitors and in vivo CAR-T.

In-Vivo 240

In-Vivo RNA Research Medicine 240

Bio Pharma Dive

MARCH 31, 2025

Accelerate biomarker research with high-quality, expert-curated data to drive precision medicine.

Medicine 246

Medicine Research 246

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 5, 2023

In order to create a pool of talented health research professionals in the country, the Indian Council of Medical Research (ICMR) has introduced a training course on “Harnessing the Power of Immunology in Medicine: Tools, Translation and Therapy”.

Research 188

Research Medicine Clinical Trials Clinical Trials 188

Rethinking Clinical Trials

FEBRUARY 12, 2025

Volandes is a professor of medicine at the Geisel School of Medicine at Dartmouth and the vice chair for research in the Department of Medicine at Dartmouth Health. Tulsky is a professor of medicine at Harvard Medical School and the Poorvu Jaffe Chair of Supportive Oncology at the Dana-Farber Cancer Institute.

Trials 144

Trials Medicine Clinical Trials Clinical Trials 144

Bio Pharma Dive

NOVEMBER 17, 2021

Chroma Medicine's launch is the latest step in a decadeslong quest by drugmakers to capitalize on research into epigenetics, a way of controlling gene expression without altering DNA.

Gene Expression 319

Gene Expression DNA Gene Medicine 319